Highlights
NASDAQ: ALDX       Aldeyra Therapeu
Last Price Today's Change   Day's Range   Trading Volume
11.10   -0.31 (2.72%)  10.81 - 12.37  919,400

Overview

 
Avg Volume (4 weeks):1,832,478
4 Weeks Range:6.47 - 14.62
4 Weeks Price Volatility (%):
56.81%
52 Weeks Range:1.48 - 14.62
52 Weeks Price Volatility (%):
73.21%
Average Price Target:-

Headlines



No recent Headlines for this stock.


Business Background

Aldeyra Therapeutics Inc is a biotechnology company operating in the US. It focuses on the development of new products for inflammation, inborn errors of metabolism, and other diseases that are thought to be related to endogenously generated toxic and pro-inflammatory chemical species known as aldehydes. The company is developing ADX-102 as well as other novel product candidates, including ADX-103 and ADX-104, which are designed specifically to sequester aldehydes for the treatment Noninfectious Anterior Uveitis, Allergic Conjunctivitis, Dry Eye Syndrome and other. The company operates through the single segment being, the Identification, and development of a treatment for diseases related to high levels of aldehydes.

  Be the first to like this.
 


APPS
I3 Messenger
Individual or Group chat with anyone on I3investor
 
 

2563  6639  404  79 

ActiveGainersLosers
Top 10 Active Counters
 NameLastChange 
 NAKD 1.38+0.988 
 AMC 19.90-0.44 
 NOK 6.55+1.56 
 SNDL 0.60+0.10 
 CTRM 0.532+0.182 
 BB 25.10+4.85 
 EXPR 9.55+1.62 
 GNUS 3.06+1.43 
 UVXY 13.87+2.47 
 AAL 16.56+1.14 

TOP ARTICLES

1. Daily Futures Trading Strategy 27 January 2021 Where Futures Lies
2. CryptoNews of the Week CryptoNews
3. Equities Slipped While Waiting For Feds State of The Markets
4. Daily Futures Trading Strategy 26 January 2021 Where Futures Lies
5. Markets Mixed Amid Stimulus Hope State of The Markets